Literature DB >> 23597597

High affinity nuclear and nongenomic estradiol binding sites in the human and mouse lens.

M Rachel Kirker1, Katie M Gallagher, Paula A Witt-Enderby, Vicki L Davis.   

Abstract

Estrogen is reported to be protective against cataracts in women and animal models. Immunodetection methods have identified the classic estrogen receptors (ER), ERα and ERβ, in human lens epithelial cells and their RNAs have been detected in the rat and human lens. To verify that estrogen binding occurs in the lens, sensitive [(125)I]-17β-estradiol binding analyses were performed on subcellular lens fractions from women (ages 39-78 years). The presence of high affinity estradiol binding sites in the nuclear, cytoplasmic, and membrane fractions indicate the lens is able to respond to estrogens, even up to age 78, although fewer binding sites were detected in the postmenopausal women. Additionally, due to the importance of mouse models in estrogen action and lens research, lenses from intact female mice were also analyzed. Both the C57BL/6 and FVB/N mouse strains also possessed high affinity binding sites in all three lens fractions. Furthermore, transcripts for ERα, ERβ, and G protein-coupled estrogen receptor (GPER; previously called GPR30) that bind estradiol with high affinity were expressed in the human and mouse lenses. These data provide the first evidence of GPER expression in the lens. Its role, functions, and subcellular location are currently unknown, but a G-shift assay in the membrane fractions of human and mouse lenses did not show evidence that estradiol induced classic G protein-coupled receptor activation. All three receptor transcripts were also detected in the lens capsule region isolated from female C57BL/6 mice, which is mainly comprised of epithelial cells. In contrast, only ERα and GPER were expressed in the cortex/nuclear region, which is primarily composed of differentiating and organelle-free fiber cells. No significant differences in specific estradiol binding and receptor RNA expression were observed in the lenses between male and female C57BL/6 mice. These findings indicate that the lens is an estrogen target tissue in both sexes. The identification of GPER, in addition to ERα and ERβ, in the lens also adds to the complexity of possible estrogen responses in the lens. Accordingly, the protective effects of estrogen in women and animals may be mediated by all three estrogen receptors in the lens. In addition, the similarities in binding and receptor RNA expression in the lenses of both species suggest that mice can be used to model estrogen action in the human lens.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597597      PMCID: PMC3786782          DOI: 10.1016/j.exer.2013.04.002

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  49 in total

1.  Identification of androgen, estrogen and progesterone receptor mRNAs in the eye.

Authors:  L A Wickham; J Gao; I Toda; E M Rocha; M Ono; D A Sullivan
Journal:  Acta Ophthalmol Scand       Date:  2000-04

2.  Sexual dimorphism and aromatase in the rat retina.

Authors:  D L Salyer; T D Lund; D E Fleming; E D Lephart; T L Horvath
Journal:  Brain Res Dev Brain Res       Date:  2001-01-31

3.  Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study.

Authors:  Barbara E K Klein; Ronald Klein; Kristine E Lee
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

4.  Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study.

Authors:  Christine Younan; Paul Mitchell; Robert G Cumming; Jai Panchapakesan; Elena Rochtchina; Angela M Hales
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

5.  Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies.

Authors:  K Worzala; R Hiller; R D Sperduto; K Mutalik; J M Murabito; M Moskowitz; R B D'Agostino; P W Wilson
Journal:  Arch Intern Med       Date:  2001-06-11

6.  Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project.

Authors:  E E Freeman; B Munoz; O D Schein; S K West
Journal:  Arch Ophthalmol       Date:  2001-11

7.  Prevalence of the different types of age-related cataract in an African population.

Authors:  N Congdon; S K West; R R Buhrmann; A Kouzis; B Muñoz; H Mkocha
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

Review 8.  Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.

Authors:  Edward J Filardo; Peter Thomas
Journal:  Endocrinology       Date:  2012-04-11       Impact factor: 4.736

9.  Sex hormones and their receptors in patients with age-related cataract.

Authors:  Xiao-Hong Zhang; Hui-Min Sun; Jian Ji; Hong Zhang; Wen-Jiang Ma; Zhi Jin; Jia-Qin Yuan
Journal:  J Cataract Refract Surg       Date:  2003-01       Impact factor: 3.351

10.  Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells.

Authors:  Patrick R Cammarata; Shaoyou Chu; Andrea Moor; Zhaohui Wang; Shao-Hua Yang; James W Simpkins
Journal:  Exp Eye Res       Date:  2004-04       Impact factor: 3.467

View more
  5 in total

1.  Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs.

Authors:  Mahmud Hasan; Mohamed Akmal Marzouk; Saugat Adhikari; Thomas D Wright; Benton P Miller; Margarite D Matossian; Steven Elliott; Maryl Wright; Madlin Alzoubi; Bridgette M Collins-Burow; Matthew E Burow; Ulrike Holzgrabe; Darius P Zlotos; Robert E Stratford; Paula A Witt-Enderby
Journal:  Mol Pharmacol       Date:  2019-06-20       Impact factor: 4.436

Review 2.  The impact of combined oral contraceptives on ocular tissues: a review of ocular effects.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States.

Authors:  Ye Elaine Wang; Caitlin Kakigi; Diego Barbosa; Travis Porco; Rebecca Chen; Sophia Wang; Yingjie Li; Kuldev Singh; Louis R Pasquale; Shan C Lin
Journal:  Ophthalmology       Date:  2016-02-11       Impact factor: 12.079

4.  Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.

Authors:  Udaya K Kotreka; Vicki L Davis; Moji C Adeyeye
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

5.  Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer.

Authors:  Han Chen; Zhi-Ming Shao; Ke-Da Yu; Ge-Zhi Xu
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.